文献速递衰弱、肌少症与跌倒老年慢病共病管理

线粒体调节药物使用与老年人骨骼肌生物能量学关联研究

Mito-Modulatory Medication Use and Skeletal Muscle Bioenergetics Among Older Men and Women: The Study of Muscle, Mobility, and Aging.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2025-01-01

本研究基于SOMMA队列,在健康老年人中评估线粒体调节药物(如他汀类和二甲双胍)使用与骨骼肌生物能量学能力的关系。通过离体高分辨率呼吸测定法和在体磷磁共振波谱测定发现,药物使用与男性较低的最大复合物I&II支持的氧化磷酸化、最大电子传递系统容量和最大ATP产生能力相关,女性中未观察到此关联,且该关联依赖于药物数量。

要点

  • 线粒体调节药物使用与男性骨骼肌最大氧化磷酸化、电子传递系统容量和ATP产生能力降低相关,女性无此关联。
  • 药物负荷越高,男性最大氧化磷酸化、电子传递系统容量和ATP产生能力越低。
  • 需随机试验验证这些药物对线粒体功能的影响。

核心结论

  • 线粒体调节药物使用与男性骨骼肌生物能量学能力降低相关,且存在药物负荷依赖性,女性中未观察到关联。

研究设计与样本

  • 基于SOMMA队列研究,纳入健康老年人,使用离体高分辨率呼吸测定法和在体磷磁共振波谱评估骨骼肌生物能量学能力。

主要发现

  • 线粒体调节药物使用与男性较低的最大复合物I&II支持的氧化磷酸化(Max OXPHOS)、最大电子传递系统容量(Max ETS)和最大ATP产生能力(ATP Max)相关,女性中无此关联。
  • 较高的线粒体调节药物负荷与男性较低的Max OXPHOS、Max ETS和ATP Max相关。

临床怎么用

  • 临床处方线粒体调节药物(如他汀类和二甲双胍)时,对老年男性应关注骨骼肌生物能量学能力的潜在影响。

局限性

  • 原文未明确报告研究设计的细节(如样本量、随访时间)及混杂因素控制情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The potential impacts of drug-induced modulation of mitochondrial function in humans remain unclear despite the high prevalence of "mito-modulatory" medication use among older adults. Although these medications, such as statins and metformin, have undergone extensive characterization of their effects on mitochondrial function in vitro, the effects in humans are far more complex and poorly understood. METHODS: This study uses data from the Study of Muscle, Mobility, and Aging (SOMMA) to evaluate how mito-modulatory medication use is related to skeletal muscle bioenergetic capacity, measured by ex vivo high-resolution respirometry and in vivo phosphorus magnetic resonance spectroscopy in healthy older adults. RESULTS: We found that mito-modulatory medication use was related to lower maximal complex I & II supported oxidative phosphorylation (Max OXPHOS), maximal electron transfer system capacity (Max ETS), and maximal ATP production capacity (ATP Max) in men, but not in women. We also found this to be dependent on the number of medications used, in which higher mito-modulatory medication load was associated with lower Max OXPHOS, Max ETS, and ATP Max. CONCLUSIONS: Our results provide greater insight into the potential clinical effects of mito-modulatory medication use and highlight the need to test the impact of these medications on mitochondrial function in randomized trials.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Phang HJ, Bergstrom J, Atayee RS, et al. Mito-Modulatory Medication Use and Skeletal Muscle Bioenergetics Among Older Men and Women: The Study of Muscle, Mobility, and Aging. J Gerontol A Biol Sci Med Sci. 2025. PMID: 40127000. doi:10.1093/gerona/glaf063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。